BlackRock, Inc. 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 2,092,281 2.500% | -4,051,327 (-65.94%) | Filing |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 6,143,608 7.300% | 319,686 (+5.49%) | Filing |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 5,823,922 9.600% | 963,782 (+19.83%) | Filing |
| 2023-02-07 2:55 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 4,860,140 8.500% | 1,160,097 (+31.35%) | Filing |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 3,700,043 8.000% | 982,114 (+36.13%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 2,717,929 6.200% | 2,717,929 (New Position) | Filing |